Effects of beta2-agonists on resident and infiltrating inflammatory cells.
about
Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseasesCan the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?Salmeterol attenuates the inflammatory response in asthma and decreases the pro-inflammatory cytokine secretion of dendritic cells.Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents.Life stress and diminished expression of genes encoding glucocorticoid receptor and beta2-adrenergic receptor in children with asthmaThree generations of ongoing controversies concerning the use of short acting beta-agonist therapy in asthma: a review.Histological effects of inhaled corticosteroids and ß2-agonists on laryngeal mucosa in an allergic rat model.Beta 2-adrenergic receptor regulation of human neutrophil function is sexually dimorphic.A comparative study of efficacy and safety of arformoterol and salbutamol nebulization as rescue therapy in acute non-severe asthma.Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.Eosinophils are key regulators of perivascular adipose tissue and vascular functionality.Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke.Overview of the pharmacogenetics of asthma treatment.(R)-albuterol decreases immune responses: role of activated T cellsβ2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway.CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.(R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS.A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma.An estimation of beta 2-adrenoceptor reserve on human bronchial smooth muscle for some sympathomimetic bronchodilators.The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro.Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?Role of mast cells in mucosal diseases: current concepts and strategies for treatment.Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts.Lysophosphatidic acid regulates trafficking of beta2-adrenergic receptors: the Galpha13/p115RhoGEF/JNK pathway stimulates receptor internalization.Procaterol upregulates peroxisome proliferator-activated receptor-gamma expression in human eosinophils.Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists.Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.A steroid-mimicking nanomaterial that mediates inhibition of human lung mast cell responsesEffects of various anti-asthmatic agents on mite allergen-pulsed murine bone marrow-derived dendritic cells.Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.Inhibitory effects of the beta-adrenergic receptor agonist zilpaterol on the LPS-induced production of TNF-alpha in vitro and in vivo.Reducing airways inflammation to prevent exacerbations in chronic obstructive pulmonary disease.Overview of novel therapeutic targets for asthma and chronic obstructive pulmonary disease.Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.Tulobuterol patch alleviates allergic asthmic inflammation by blockade of Syk and NF-κB activation in mice.Treatment with beta2-adrenoceptor agonist in vivo induces human clock gene, Per1, mRNA expression in peripheral blood.
P2860
Q28083987-B6B39138-7F06-4E9D-AEED-050B046B32E8Q28391808-687CD918-D302-4582-A4BA-FCD94C608496Q33577392-6B217934-F7FA-4BA0-B469-D5353C74A800Q34081764-1E0849A4-CF3E-4728-8992-9CEB76D71AF3Q34481730-56F3CCF8-5E13-4E01-B27F-C255B185AA83Q34747731-8B42F958-6B7F-4EC0-9D0F-DBC3437ABADBQ34811084-B4AA5359-0D94-4C33-BBC4-A2EEEFB8B53BQ35048442-3E45944D-0548-42F6-B697-3A9F5CDE93CEQ35157123-A3CCE4B7-BC41-42DB-9694-1794EFE4E287Q35825799-5855B2D7-1E30-46C8-95B1-630554D434FAQ36311728-5702AAD4-9822-4398-A5B9-574257446F68Q36372827-1231E465-7B77-48A1-8FCD-EDEB0789B453Q36433595-49B2C0C1-9386-4E89-9F58-2AB1E2278CB0Q36477130-59CAE7E1-3F6E-49DA-8F13-B8C562AFCE18Q36756664-F4321149-4F82-4D17-9949-A70B5ADC937AQ36858348-15BE5198-53A6-4D35-8509-6F3A3DBB7397Q37101038-C80A9C74-D3ED-41FB-A10A-2E3078BC170AQ37135100-A3D2B6B7-C717-4D6C-B0D8-C9820973854BQ37481283-22D4A2DE-B698-434C-885C-7F9B20893F14Q37661542-15A0C8F5-C6B2-4A81-A206-BD9D9F139F57Q37951672-3711E3E0-3D01-4B90-87F5-6FE42692AF5BQ38068961-CF323A1F-9AB3-4C11-A95D-D95B158C2BA2Q38959067-DEDD6B05-F3C6-4028-B9CA-93EDF63781A4Q40036240-5EBE0D94-674B-4AA4-A43F-21AC1F8E1101Q40134420-47EE88E2-D2F8-4946-9E4C-332D66676987Q40268290-29B2203A-7218-4AA0-BE13-654B2C70B2EAQ40432011-93412C34-3933-43DC-B209-2854DF96785AQ42001057-DED68D5F-146C-49E9-B2F8-602145A2E684Q42543826-E0624137-1339-418F-9CCE-766BC84F15C7Q46594170-4BA7FA00-F999-4178-8AB3-D5FC98B66F63Q46704685-A8512CBC-11CD-41BF-81D4-6F0E4408F89FQ46846892-D87B5CEB-7842-48D3-A407-993B305E8A8CQ47718396-BD376D12-B575-440C-A599-BEAE615EECFAQ47772639-2E9CFB65-3EB7-44BE-B094-249CA25D3422Q48496612-39DC982C-0CC0-4BD1-9C54-C9A785B974C0Q51738702-4BF4409F-DE19-412B-9FC5-A8BEBEF223B3Q53565351-09DBC5C6-62ED-4AD7-89EF-D7661BBFE65D
P2860
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
@ast
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
@en
type
label
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
@ast
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
@en
prefLabel
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
@ast
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
@en
P356
P1476
Effects of beta2-agonists on resident and infiltrating inflammatory cells.
@en
P2093
Malcolm Johnson
P304
P356
10.1067/MAI.2002.129430
P407
P433
P577
2002-12-01T00:00:00Z